Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2024-09-10 EDT 5-day change 1st Jan Change
17.72 USD +0.85% Intraday chart for Integra LifeSciences Holdings Corporation -8.04% -59.31%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Integra LifeSciences Holdings Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-06-2024 10:45 AM
Premier, Inc. Announces Chief Financial Officer Changes CI
Premier, Inc. Announces Executive Changes CI
Tech giants dish out the numbers amid Fed watch Our Logo
BTIG Downgrades Integra LifeSciences Holdings to Sell From Neutral, Price Target is $22 MT
Citigroup Downgrades Integra LifeSciences Holdings to Sell From Neutral, Adjusts Price Target to $23 From $30 MT
Analyst recommendations: 3M Company, Aon, Murphy USA, Skyworks, Tesla... Our Logo
Truist Adjusts Price Target on Integra LifeSciences Holdings to $26 From $32 After 'Big' H2 Guide Cut, Maintains Hold Rating MT
Integra LifeSciences Shares Drop After Company Cuts Full-Year Outlook MT
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday MT
Sector Update: Health Care MT
Correction: Integra LifeSciences Q2 Adjusted Earnings Fall, Revenue Rises; Lowers 2024 Outlook MT
Transcript : Integra LifeSciences Holdings Corporation, Q2 2024 Earnings Call, Jul 29, 2024
Integra LifeSciences Q2 Adjusted Earnings, Revenue Fall; Lowers 2024 Outlook MT
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q2 Revenue $418.2M, vs. Street Est of $413.1M MT
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Reports Q2 EPS $0.63, vs. Street Est of $0.62 MT
Integra LifeSciences Holdings Corporation Provides Earnings Guidance for the Third Quarter and Updates Earnings Guidance for the Full Year of 2024 CI
Integra LifeSciences Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating MT
Integra LifeSciences to Shift PriMatrix, SurgiMend Production to New Braintree, Massachusetts Facility by 2026 MT
Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating MT
Integra LifeSciences Holdings Corporation Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Defensive Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell Midcap Value Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell 1000 Index CI
Chart Integra LifeSciences Holdings Corporation
More charts
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Employees
3,946
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
17.72USD
Average target price
27.70USD
Spread / Average Target
+56.32%
Consensus
  1. Stock Market
  2. Equities
  3. IART Stock
  4. News Integra LifeSciences Holdings Corporation
  5. Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW